title: Corrigendum to "Targeted gold nanoparticles enhance sensitization of prostate tumors to megavoltage radiation therapy in vivo" [Nanomedicine: Nanotechnology, Biology, and Medicine 11 (2015) 1277-1283].
authors.affiliation: The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
authors.forename: Tatiana
authors.initials: T
authors.lastname: Wolfe
authors.affiliation: The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
authors.forename: Dev
authors.initials: D
authors.lastname: Chatterjee
authors.affiliation: The University of Texas MD Anderson Cancer Center, Houston, TX, USA; SoonChunHyang University Hospital, Seoul, South Korea.
authors.forename: Jihyoun
authors.initials: J
authors.lastname: Lee
authors.affiliation: The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
authors.forename: Jonathan D
authors.initials: JD
authors.lastname: Grant
authors.affiliation: The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
authors.forename: Shanta
authors.initials: S
authors.lastname: Bhattarai
authors.affiliation: The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
authors.forename: Ramesh
authors.initials: R
authors.lastname: Tailor
authors.affiliation: Nanospectra Biosciences Inc., Houston, TX, USA.
authors.forename: Glenn
authors.initials: G
authors.lastname: Goodrich
authors.affiliation: University of Sao Paulo, Ribeirão Preto, Sao Paulo, Brazil.
authors.forename: Patricia
authors.initials: P
authors.lastname: Nicolucci
authors.affiliation: The University of Texas MD Anderson Cancer Center, Houston, TX, USA. Electronic address: skrishnan@mdanderson.org.
authors.forename: Sunil
authors.initials: S
authors.lastname: Krishnan